AzTrials
AzTrials

RelaxationRELAXPENCT05546307

Interest of Prior Relaxation on the Recordings of the SomatoSensory Evoked Potentials

A study testing SSEP and relaxation session in people with Relaxation and Somatosensory Evoked Potentials, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Many factors influence the quality and duration of SomatoSensory Evoked potentials (SSEP). Some are related to the technique : type of electrodes, intensity of stimulation, stimulation site ; others are related to the patient : poor state of relaxation of the patient generating muscle artefacts; hypersensitivity of… Read more about this study

Who is it for?
Ages 18 to 70 years
What is being tested?
SSEP and relaxation session
Could I receive a placebo?
No, everyone receives an active treatment
How many people
242 participants
Where
1 siteFrance
Study dates
15 Sep 2022to Jul 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Any patient addressed for a study of the somatosensory evoked potentials in upper limbs
  • Patients between 18 to 70 years old.
  • Patients able to understand the instructions of the relaxation session and the examination.
  • Patient providing informed consent exclusion criteria

Who cannot join

  • No availability of a technician trained in relaxation
  • Patient's refusal to participate in the protocol

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Amiens University Hospital

    Amiens, Picardie, 80054

    Caroline CARRE, 03 22 08 77 76, carre.caroline@chu-amiens.fr

    Philippe-Edouard MERLE, Dr

    Recruiting

Other trials in France

About this study

Official title: Randomized, Single-blind Study Evaluating the Interest of Prior Relaxation on the Quality of the Recordings of the SomatoSensory Evoked Potentials

Many factors influence the quality and duration of SomatoSensory Evoked potentials (SSEP). Some are related to the technique : type of electrodes, intensity of stimulation, stimulation site ; others are related to the patient : poor state of relaxation of the patient generating muscle artefacts; hypersensitivity of the patient to electrical stimuli making the examination unpleasant; examination time considered too long. However, the patient's relaxed state is essential to the quality of the signal . Thus the duration of an examination is very variable : between 30 and 75 minutes for the upper limbs.... For several months, the investigators provide relaxation to some patients just before the examination. Results seem to be positive. The investigators aim to study the effect of relaxation session on the quality of the SSEP recordings. Fifteen-minutes relaxation session will be provided by a nurse trained to the relaxation.

The investigators will compare two groups : one group with one relaxation session before the examination and one group without relaxation session before the examination.

The investigators chose to study the influence of relaxation session on (i) the artifacts rejection rate by the machine for the recordings of SSEP by stimulation of the median nerve to the upper limbs (ii) the duration of the examination (iii) the patient experience

Being tested
SSEP, relaxation session
Keywords
Relaxation, Somatosensory Evoked Potentials, Patient experience

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SSEPOther

    Every patient presenting for a SSEP will be offered to participate to the study. If accepted, a randomization will determine whether the examination will be preceded by a relaxation session (Relax Group) or not (control group)

  • relaxation sessionOther

    The relaxation session will be performed by one of the 5 nurses trained in relaxation

Study groups in NCT05546307
Study groupRoleWhat they receive
one relaxation session before the examinationExperimentalNot described
Receives: Other: SSEP; Other: relaxation session
No relaxation session before the examinationActive comparatorNot described
Receives: Other: SSEP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Variation of average rate of automatized artifacts rejection between both groups

    Average rate of automatized artifacts rejection during 2 sessions of 1000 stimulations on the first stimulated limb to obtain the N13 wave

    Measured: 19 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2022
  2. Study start15 Sep 2022
  3. Primary completionJul 2025 (estimated)
  4. Study completionJul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
242 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05546307
Sponsor's protocol ID
PI2019_843_0079
Acronym
RELAXPE
Status last verified
Jun 2025
First submitted
15 Sep 2022
Last updated
4 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing SSEP and relaxation session in people with Relaxation and Somatosensory Evoked Potentials, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Caroline CARRE (03 22 08 77 76, carre.caroline@chu-amiens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Variation of average rate of automatized artifacts rejection between both groups (time frame: 19 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
RELAXPE Clinical Trial NCT05546307 | AzTrials